Updated Jul 16, 2026 · Last SEC filing 2026-07-08
Candel Therapeutics, Inc. (CADL) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-08. 4 Form 8-K material event filings were reported by CADL in the last 90 days. 2 Form 144 notices of proposed sale were filed for CADL stock. InsiderAlpha tracks every CADL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001841387 |
|---|
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-08 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Tyagarajan Seshu | Chief Technology Officer | S — Open-market sale | 7.0K | $10.02 | $70K | SEC | |
| Barone Francesca | Chief Scientific Officer | S — Open-market sale | 23.4K | $10.06 | $236K | SEC | |
| Manning Paul B | Insider | P — Open-market purchase | 550.5K | $5.45 | $3.00M | SEC | |
| Nichols William Garrett | Chief Medical Officer | M — Option exercise | 937 | $1.29 | $1K | SEC | |
| Nichols William Garrett | Chief Medical Officer | S — Open-market sale | 937 | $6.98 | $7K | SEC | |
| Nichols William Garrett | Chief Medical Officer | S — Open-market sale | 781 | $5.04 | $4K | SEC | |
| Nichols William Garrett | Chief Medical Officer | M — Option exercise | 781 | $1.29 | $1K | SEC | |
| PAPA JOSEPH C | Insider | A — Grant or award | 64.2K | $4.67 | $300K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $8.85 | $442K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $8.85 | $442K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $9.01 | $450K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $9.01 | $450K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $8.82 | $441K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $8.82 | $441K | SEC | |
| Aguilar-Cordova Estuardo | 10% Owner | D — Derivative transaction | 50.0K | $8.52 | $426K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Candel Therapeutics, Inc. (CADL). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Loggia Nicoletta | 2 | $3K |
| PAPA JOSEPH C | 2 | $11K |
| Manning Paul B | 2 | $19K |
| Barone Francesca | 1 | $236K |
| Nguyen Diem | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CADL insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CADL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.